D
Voyageur Pharmaceuticals Ltd. VM.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

02/28/2025 11/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 61.11% 26.84%
Depreciation & Amortization -33.33% 0.00%
Other Operating Expenses -- --
Total Operating Expenses 61.02% 26.81%
Operating Income -61.02% -26.81%
Income Before Tax -71.41% -27.12%
Income Tax Expenses -- --
Earnings from Continuing Operations -71.41% -27.12%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -71.41% -27.12%
EBIT -61.02% -26.81%
EBITDA -61.11% -26.84%
EPS Basic -54.17% -26.32%
Normalized Basic EPS -53.33% -25.00%
EPS Diluted -54.17% -26.32%
Normalized Diluted EPS -53.33% -25.00%
Average Basic Shares Outstanding 11.57% -0.04%
Average Diluted Shares Outstanding 11.57% -0.04%
Dividend Per Share -- --
Payout Ratio -- --